Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019–2021

Summary We report the outcome of 563 cases of newly diagnosed lymphoma registered in 2019–2021, including 176 cases (31.2%) of Hodgkin lymphoma (HL), 130 (23.1%) of diffuse large B‐cell lymphoma (DLBCL), 28 (5%) of follicular lymphoma (FL), 16 (2.9%) of mantle cell lymphoma (MCL) and 20 (3.5%) of pe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2024-05, Vol.204 (5), p.1757-1761
Hauptverfasser:	Stepanishyna, Yana, Manni, Martina, Civallero, Monica, Shokun, Nazar, Skrypets, Tetiana, Burtna, Alevtyna, Shapovalenko, Natalia, Tytorenko, Iryna, Aleksyk, Olena, Pastushenko, Yan, Gubareva, Hanna, Moiseienko, Kateryna, Kadnikova, Tetyana, Rudyuk, Timur, Filonenko, Kateryna, Martynchyk, Arina, Novosad, Olga, Galli, Giulia R., Kryachok, Irina, Federico, Massimo
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic lymphocytic leukemia Hodgkin's lymphoma lymphoma registry malignant lymphoma Mantle cell lymphoma survival outcomes T-cell lymphoma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Summary We report the outcome of 563 cases of newly diagnosed lymphoma registered in 2019–2021, including 176 cases (31.2%) of Hodgkin lymphoma (HL), 130 (23.1%) of diffuse large B‐cell lymphoma (DLBCL), 28 (5%) of follicular lymphoma (FL), 16 (2.9%) of mantle cell lymphoma (MCL) and 20 (3.5%) of peripheral T‐cell lymphoma (PTCL). After a median follow‐up of 30.1 months (95% CI: 28.8–31.3), the 3‐year overall survival rates were 95%, 83%, 86%, 100%, 61% and 42% for HL, DLBCL, CLL, FL, MCL and PTCL respectively. These data offer valuable information on the curability of lymphoma patients in Ukraine, in a real‐world setting.
ISSN:	0007-1048 1365-2141
DOI:	10.1111/bjh.19352